Aptose Biosciences Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
653.00
30,386.00
19,748.00
10,662.00
14,320.00
21,496.30
Other Current Assets
365.00
495.00
1,067.00
663.00
496.20
1,020.30
Total Current Assets
1,018.00
30,881.00
20,815.00
11,325.00
14,816.10
22,516.60
Net Property, Plant & Equipment
17.00
18.00
368.00
252.00
177.90
524.50
Intangible Assets
-
-
66.00
33.00
-
-
Total Assets
1,035.00
30,899.00
21,249.00
11,610.00
14,994.10
23,041
Accounts Payable
713.00
649.00
-
-
-
Other Current Liabilities
1,103.00
1,283.00
2,356.00
1,770.00
2,211.50
Total Current Liabilities
1,816.00
1,932.00
2,356.00
1,770.00
2,211.50
Long-Term Debt
-
616.00
-
-
-
Total Liabilities
1,816.00
2,548.00
2,356.00
1,770.00
2,211.50
Common Equity (Total)
781.00
28,351.00
18,893.00
9,840.00
12,782.60
Total Shareholders' Equity
781.00
28,351.00
18,893.00
9,840.00
12,782.60
Total Equity
781.00
28,351.00
18,893.00
9,840.00
12,782.60
Liabilities & Shareholders' Equity
1,035.00
30,899.00
21,249.00
11,610.00
14,994.10
About Aptose Biosciences
View Profile
